Status:
RECRUITING
Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Canadian Cancer Society (CCS)
Conditions:
Medication Adherence
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this feasibility study is to co-create and evaluate a theory informed, evidence-based, patient-centered healthbot aimed at helping people adhere to their varenicline regimen. The main rese...
Detailed Description
A: Co-design a theory informed healthbot to support patients' adherence to varenicline: The investigators will employ a user-centred approach to build the healthbot in order to optimize user experien...
Eligibility Criteria
Inclusion
- Treatment-seeking smokers who are willing to start taking varenicline and continue it for 12 weeks, and set a quit date in the next 30 days;
- Smoke cigarettes daily (10 or more cigarettes a day)
- Age ≥ 18 years;
- Speak/read English;
- Have a smartphone with data plan;
- Report being committed to answering questions during follow-up;
- Live in Ontario.
Exclusion
- Have contraindication(s) to varenicline use;
- Are pregnant/planning to become pregnant/breastfeeding;
- Participated in the co-design phase.
Key Trial Info
Start Date :
October 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 12 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05997901
Start Date
October 12 2022
End Date
September 12 2025
Last Update
January 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J1H4